Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756923 · ClinicalTrials.gov registry record
Regulation of Stem Spermatogonia in the Mature Testis
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 142
- Enrollment target
NCT02756923: Completed study, sponsored by Weill Medical College of Cornell University.
NCT02756923 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 142 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02756923 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 142 participants
- Enrollment target
Study Summary
Investigative trial to evaluate the role of a glial cell lined derived neurotrophic factor (GDNF) in regulation of spermatogonial renewal and testicular function. Goal of the trial is to provide greater information on the mechanisms that effect stem spermatogonial maintenance renewal and proliferation in its relation to male infertility.
Primary Outcome
Levels of glial cell line derived neurotrophic factor (GDNF) in normal testis compared to abnormal testicular tissue.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2012-04 |
| Est. Completion | 2019-12-05 |
What the finished NCT02756923 record still lists
NCT02756923 is an observational study that tracks outcomes without assigning an intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02756923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02756923 about?
NCT02756923 is a clinical study titled "Regulation of Stem Spermatogonia in the Mature Testis". Investigative trial to evaluate the role of a glial cell lined derived neurotrophic factor (GDNF) in regulation of spermatogonial renewal and testicular function. Goal of the trial is to provide greater information on the mechanisms that effect stem spermatogonial maintenance renewal and proliferati...
What is the current status of trial NCT02756923?
This trial is currently completed. The enrollment target is 142 participants. The study started on 2012-04. Estimated completion is 2019-12-05.
Who is sponsoring clinical trial NCT02756923?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia